Advances in the treatment of patients with Hodgkin lymphoma

Abstract

Hodgkin lymphoma (HL) is lymphoid neoplasm showing a favourable patient prognosis. This article summarizes advances made within the last 5 years in the treatment of patients with HL; the most important being positron emission tomography used for assessing early on how effective treatments are and for cases where monoclonal antibodies in relapse settings are introduced.